Novolin r and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Novolin r (insulin recombinant purified human), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Novolog, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Novolin r. It is created by eHealthMe based on reports of 4,529 people who have side effects when taking Novolin r from the FDA, and is updated regularly.

What is Novolin r?

Novolin r has active ingredients of insulin recombinant purified human. It is often used in type 1 diabetes. eHealthMe is studying from 4,568 Novolin r users. Check the latest studies of Novolin r.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,750 drugs and 2,915 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

4,529 people reported to have side effects when taking Novolin r.
Among them, 57 people (1.26%) have Hypersensitivity.

Among these 57 people:

How long have people been on Novolin r when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Novolin r? *

female: 72.55 %
male: 27.45 %

What is the age of people who have Hypersensitivity when taking Novolin r? *

What are other drugs people take besides Novolin r? *

Humulin R: 7 people, 12.28%
Lantus: 7 people, 12.28%
Novolog: 7 people, 12.28%
Lisinopril: 6 people, 10.53%
Novolin N: 6 people, 10.53%
Metformin: 5 people, 8.77%
Norvasc: 5 people, 8.77%
Ritalin: 4 people, 7.02%
Bentyl: 4 people, 7.02%
Chlorhexidine Gluconate: 4 people, 7.02%

What are other side effects people have besides Hypersensitivity? *

Malaise (a feeling of general discomfort or uneasiness): 13 people, 22.81%
Chest Pain: 10 people, 17.54%
Blood Glucose Increased: 10 people, 17.54%
Weakness: 8 people, 14.04%
Itching: 6 people, 10.53%
Fatigue (feeling of tiredness): 6 people, 10.53%
Diarrhea: 6 people, 10.53%
Hypotension (abnormally low blood pressure): 6 people, 10.53%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 8.77%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 5 people, 8.77%

What are the existing conditions these people have? *

Type 2 Diabetes: 14 people, 24.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 7.02%
Asthma: 3 people, 5.26%
Pain: 3 people, 5.26%
High Blood Cholesterol: 3 people, 5.26%
High Blood Pressure: 3 people, 5.26%
Insulin-Requiring Type 2 Diabetes Mellitus: 2 people, 3.51%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 3.51%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 2 people, 3.51%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 3.51%

* Approximation only. Some reports may have incomplete information.

Do you take Novolin r and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolin r:

Novolin r (4,568 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

How severe was Hypersensitivity and when was it recovered:

Hypersensitivity in Novolin r

Expand to all the drugs that have ingredients of insulin recombinant purified human:

Hypersensitivity and drugs with ingredients of insulin recombinant purified human

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novolin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,750 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,915 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant purified human (the active ingredients of Novolin r) and Novolin r (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.